Cargando…

Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users

BACKGROUND: Mucosally acquired human immunodeficiency virus type 1 (HIV-1) infection results from a limited number of variants, and these infecting strains potentially have unique properties, such as increased susceptibility to entry blockers, relative interferon-alpha (IFN-α) resistance, and replic...

Descripción completa

Detalles Bibliográficos
Autores principales: Etemad, Behzad, Gonzalez, Oscar A, White, Laura, Laeyendecker, Oliver, Kirk, Gregory D, Mehta, Shruti, Sagar, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253609/
https://www.ncbi.nlm.nih.gov/pubmed/25430652
http://dx.doi.org/10.1186/s12977-014-0106-8
_version_ 1782347264766771200
author Etemad, Behzad
Gonzalez, Oscar A
White, Laura
Laeyendecker, Oliver
Kirk, Gregory D
Mehta, Shruti
Sagar, Manish
author_facet Etemad, Behzad
Gonzalez, Oscar A
White, Laura
Laeyendecker, Oliver
Kirk, Gregory D
Mehta, Shruti
Sagar, Manish
author_sort Etemad, Behzad
collection PubMed
description BACKGROUND: Mucosally acquired human immunodeficiency virus type 1 (HIV-1) infection results from a limited number of variants, and these infecting strains potentially have unique properties, such as increased susceptibility to entry blockers, relative interferon-alpha (IFN-α) resistance, and replication differences in some primary cells. There is no data about the phenotypic properties of HIV-1 envelope variants found early after acquisition among subjects infected through injection drug use (IDU). For the first time, we compared the characteristics of virus envelopes among injection drug users sampled prior to seroconversion (HIV RNA+/Ab-), within 1 year (early), and more than 2 years (chronic) after estimated acquisition. RESULTS: Virus envelopes from 7 HIV RNA+/Ab- subjects possessed lower genetic diversity and divergence compared to 7 unrelated individuals sampled during the chronic phase of disease. Replication competent recombinant viruses incorporating the HIV RNA+/Ab- as compared to the chronic phase envelopes were significantly more sensitive to a CCR5 receptor inhibitor and IFN-α and showed a statistical trend toward greater sensitivity to a fusion blocker. The early as compared to chronic infection envelopes also demonstrated a statistical trend or significantly greater sensitivity to CCR5 and fusion inhibitor and IFN- α. The HIV RNA+/Ab- as compared to chronic envelope viruses replicated to a lower extent in mature monocyte derived dendritic cells – CD4+ T cell co-cultures, but there were no significant replication differences in other primary cells among the viruses with envelopes from the 3 different stages of infection. CONCLUSIONS: Similar to mucosal acquisition, HIV-1 envelope quasispecies present in injection drug users prior to seroconversion have unique phenotypic properties compared to those circulating during the chronic phase of disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-014-0106-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4253609
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42536092014-12-04 Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users Etemad, Behzad Gonzalez, Oscar A White, Laura Laeyendecker, Oliver Kirk, Gregory D Mehta, Shruti Sagar, Manish Retrovirology Research BACKGROUND: Mucosally acquired human immunodeficiency virus type 1 (HIV-1) infection results from a limited number of variants, and these infecting strains potentially have unique properties, such as increased susceptibility to entry blockers, relative interferon-alpha (IFN-α) resistance, and replication differences in some primary cells. There is no data about the phenotypic properties of HIV-1 envelope variants found early after acquisition among subjects infected through injection drug use (IDU). For the first time, we compared the characteristics of virus envelopes among injection drug users sampled prior to seroconversion (HIV RNA+/Ab-), within 1 year (early), and more than 2 years (chronic) after estimated acquisition. RESULTS: Virus envelopes from 7 HIV RNA+/Ab- subjects possessed lower genetic diversity and divergence compared to 7 unrelated individuals sampled during the chronic phase of disease. Replication competent recombinant viruses incorporating the HIV RNA+/Ab- as compared to the chronic phase envelopes were significantly more sensitive to a CCR5 receptor inhibitor and IFN-α and showed a statistical trend toward greater sensitivity to a fusion blocker. The early as compared to chronic infection envelopes also demonstrated a statistical trend or significantly greater sensitivity to CCR5 and fusion inhibitor and IFN- α. The HIV RNA+/Ab- as compared to chronic envelope viruses replicated to a lower extent in mature monocyte derived dendritic cells – CD4+ T cell co-cultures, but there were no significant replication differences in other primary cells among the viruses with envelopes from the 3 different stages of infection. CONCLUSIONS: Similar to mucosal acquisition, HIV-1 envelope quasispecies present in injection drug users prior to seroconversion have unique phenotypic properties compared to those circulating during the chronic phase of disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-014-0106-8) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-28 /pmc/articles/PMC4253609/ /pubmed/25430652 http://dx.doi.org/10.1186/s12977-014-0106-8 Text en © Etemad et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Etemad, Behzad
Gonzalez, Oscar A
White, Laura
Laeyendecker, Oliver
Kirk, Gregory D
Mehta, Shruti
Sagar, Manish
Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users
title Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users
title_full Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users
title_fullStr Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users
title_full_unstemmed Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users
title_short Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users
title_sort characterization of hiv-1 envelopes in acutely and chronically infected injection drug users
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253609/
https://www.ncbi.nlm.nih.gov/pubmed/25430652
http://dx.doi.org/10.1186/s12977-014-0106-8
work_keys_str_mv AT etemadbehzad characterizationofhiv1envelopesinacutelyandchronicallyinfectedinjectiondrugusers
AT gonzalezoscara characterizationofhiv1envelopesinacutelyandchronicallyinfectedinjectiondrugusers
AT whitelaura characterizationofhiv1envelopesinacutelyandchronicallyinfectedinjectiondrugusers
AT laeyendeckeroliver characterizationofhiv1envelopesinacutelyandchronicallyinfectedinjectiondrugusers
AT kirkgregoryd characterizationofhiv1envelopesinacutelyandchronicallyinfectedinjectiondrugusers
AT mehtashruti characterizationofhiv1envelopesinacutelyandchronicallyinfectedinjectiondrugusers
AT sagarmanish characterizationofhiv1envelopesinacutelyandchronicallyinfectedinjectiondrugusers